vTv Therapeutics Inc. , a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes.
Vtv Therapeutics stock last closed at $19.95, down 3.99% from the previous day, and has decreased 28.49% in one year. It has overperformed other stocks in the Biotechnology industry by 0.48 percentage points. Vtv Therapeutics stock is currently +64.6% from its 52-week low of $12.12, and -31.42% from its 52-week high of $29.09.
As of Apr 30, 2025, there are 3.19M VTVT shares outstanding. The market cap of VTVT is $63.63M. In the past 24 hours, 5089 VTVT shares were traded.
How to Buy Vtv Therapeutics Stock
Not sure how to invest in Vtv Therapeutics stock? Here's how.
Choose where to buy Vtv Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you choose where to buy Vtv Therapeutics stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit money your investment account: Pick your method of payment and add your information.
Analyze Vtv Therapeutics stock: The Vtv Therapeutics ticker symbol is VTVT. Is Vtv Therapeutics stock a good investment? Should you buy shares of VTVT? How do VTVT's underlying business fundamentals look? Do top analysts think Vtv Therapeutics is a good buy? Why has VTVT's stock price moved recently? (Hint: Our stock research website can help you figure out if VTVT is a good stock to buy).
Place your VTVT buy order: Decide if you will purchase VTVT shares at the current market price or use a limit order to buy VTVT shares at a given price.
Get the latest scoop on your VTVT investment: Create a watchlist to keep tabs on your position in Vtv Therapeutics shares.
Step 1: Choose where to buy Vtv Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy VTVT shares.
A brokerage account is an investment account that allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to world markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected the best brokerage, the next step is to fill out some personal info so you can invest in VTVT stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Vtv Therapeutics stock
Once you have selected the best place to buy Vtv Therapeutics stock, it's critical to research their stock before you invest, so you can wrap your head around the risk and opportunity.
Vtv Therapeutics shares data
VTVT Price
$19.95
1w %
-2.92%
1y %
-28.49%
5y %
-76.25%
P/E
-6.23x
P/B
5.22x
P/S
62.54x
PEG
N/A
Revenue
$1.02M
Earnings
-$18.46M
Fore. Rev. Growth
333.18%
Fore. Earn. Growth
N/A
Market Cap
$63.63M
Next Earnings
May 7, 2025
Next Dividend
N/A
VTVT Due Diligence Score
WallStreetZen was created to help part-time investors do more in-depth fundamental analysis in minutes instead of hours.
Last year, VTVT revenue was $1.02M. Over the last five year, VTVT's revenue has grown by -18.12% per year. This was slower than the Biotechnology industry average of 45.66%.
Over the last 12 months, executives and large shareholders at VTVT have bought more shares than they have sold.
Paul J. Sekhri, Pres CEO and Exec Chairperson of VTVT, was the latest VTVT insider to buy. They bought $31,268.71 worth of VTVT shares on Nov 18, 2024.
No, Vtv Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about VTVT
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your VTVT buy order
There are two primary order types:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are generally fine.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a specific dollar amount limit, use a limit order.
Hit the Open Trade button and your broker will place your order.
If you want more info about buying stocks on eToro, click the helpful video below:
How much does it cost to buy one Vtv Therapeutics share?
As of Apr 30, 2025, it costs $19.95 to buy one share of Vtv Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $9, you can buy 0.451 shares of VTVT.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.